Evidence map›Paper›PMID 34731436›Full record

ArticleJournal of general internal medicine2022

Clinical Outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention.

Franya Hutchins, Joshua Thorpe, Matthew L Maciejewski, Xinhua Zhao, Karin Daniels, Hongwei Zhang, Donna M Zulman, Stephan Fihn, Sandeep Vijan, Ann-Marie Rosland

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Franya HutchinsCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA. Franya.Hutchins@va.gov.ORCID 0000-0002-8797-2632
Joshua ThorpeCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA.
Matthew L MaciejewskiDepartment of Population Health Sciences, Duke University Medical Center, Durham, NC, USA.
Xinhua ZhaoCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA.
Karin DanielsCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA.
Hongwei ZhangCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA.
Donna M ZulmanDivision of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Stephan FihnDivision of General Internal Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Sandeep VijanVA Center for Clinical Management Research, Ann Arbor, MI, USA.
Ann-Marie RoslandCenter for Health Equity Research and Promotion, VA Pittsburgh Health Care System, University Drive (151C), Pittsburgh, PA, 15240, USA.
University of Pittsburgh · USVA Pittsburgh Healthcare System · USDuke University · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USVA Palo Alto Health Care System · US

Funding

HSR&D Senior Research Career Scientist AwardIK6HX003157 · VA · DURHAM VA MEDICAL CENTER · PI MATTHEW L MACIEJEWSKI · 2020 to 2026
–
HSRD VA IK6 HX003157
6 · The paper itself

Abstract

backgroundThe ability of latent class models to identify clinically distinct groups among high-risk patients has been demonstrated, but it is unclear how healthcare data can inform group-specific intervention design.

objectiveExamine how utilization patterns across latent groups of high-risk patients provide actionable information to guide group-specific intervention design.

designCohort study using data from 2012 to 2015. PATIENTS: Participants were 934,787 patients receiving primary care in the Veterans Health Administration, with predicted probability of 12-month hospitalization in the top 10 MAIN MEASURES: Patients were assigned to latent groups via mixture-item response theory models based on 28 chronic conditions. We modeled odds of all-cause mortality, hospitalizations, and 30-day re-hospitalizations by group membership. Detailed outpatient and inpatient utilization patterns were compared between groups. KEY

resultsA total of 764,257 (81.8%) of patients were matched with a comorbidity group. Groups were characterized by substance use disorders (14.0% of patients assigned), cardiometabolic conditions (25.7%), mental health conditions (17.6%), pain/arthritis (19.1%), cancer (15.3%), and liver disease (8.3%). One-year mortality ranged from 2.7% in the Mental Health group to 14.9% in the Cancer group, compared to 8.5% overall. In adjusted models, group assignment predicted significantly different odds of each outcome. Groups differed in their utilization of multiple types of care. For example, patients in the Pain group had the highest utilization of in-person primary care, with a mean (SD) of 5.3 (5.0) visits in the year of follow-up, while the Substance Use Disorder group had the lowest, with 3.9 (4.1) visits. The Substance Use Disorder group also had the highest rates of using services for housing instability (25.1%), followed by the Liver group (10.1%).

conclusionsLatent groups of high-risk patients had distinct hospitalization and utilization profiles, despite having comparable levels of predicted baseline risk. Utilization profiles pointed towards system-specific care needs that could inform tailored interventions.

Indexed as

HospitalizationSubstance-Related DisordersCohort StudiesHumansInpatientsPaindelivery of healthcarehospitalizationlatent class analysismultiple chronic conditionsVeterans health

Identifiers

PMID34731436
PMCPMC9360385
OpenAlexW3211293215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.